Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology).
Palumbo I, Borghesi S, Gregucci F, Falivene S, Fontana A, Aristei C, Ciabattoni A. Palumbo I, et al. Among authors: borghesi s. J Geriatr Oncol. 2021 Sep;12(7):1130-1135. doi: 10.1016/j.jgo.2021.05.008. Epub 2021 May 19. J Geriatr Oncol. 2021. PMID: 34020908 Free PMC article. Review.
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G. Macchia G, et al. Among authors: borghesi s. Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10. Oncologist. 2020. PMID: 32043791 Free PMC article.
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series.
Francolini G, Detti B, Bottero M, Zilli T, Lancia A, Bruni A, Borghesi S, Mariotti M, Castellucci P, Fanti S, Filippi AR, Teriaca MA, Maragna V, Aristei C, Mazzeo E, Livi L, Ingrosso G. Francolini G, et al. Among authors: borghesi s. Clin Transl Oncol. 2021 Feb;23(2):364-371. doi: 10.1007/s12094-020-02427-2. Epub 2020 Jun 29. Clin Transl Oncol. 2021. PMID: 32602076
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Francolini G, Borghesi S, Fersino S, Magli A, Jereczek-Fossa BA, Cristinelli L, Rizzo M, Corvò R, Pappagallo GL, Arcangeli S, Magrini SM, D'Angelillo RM. Francolini G, et al. Among authors: borghesi s. Crit Rev Oncol Hematol. 2021 Mar;159:103235. doi: 10.1016/j.critrevonc.2021.103235. Epub 2021 Jan 22. Crit Rev Oncol Hematol. 2021. PMID: 33493633 Free article. Review.
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy.
Ingrosso G, Detti B, Fodor A, Caini S, Borghesi S, Triggiani L, Trippa F, Russo D, Bruni A, Francolini G, Lancia A, Marinelli L, Di Muzio N, Livi L, Magrini SM, Maranzano E, Musio D, Aristei C, Valeriani M. Ingrosso G, et al. Among authors: borghesi s. Clin Transl Oncol. 2021 Aug;23(8):1577-1584. doi: 10.1007/s12094-021-02553-5. Epub 2021 Jan 25. Clin Transl Oncol. 2021. PMID: 33495981
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues?
Fozza A, Giaj-Levra N, De Rose F, Ippolito E, Silipigni S, Meduri B, Fiorentino A, Gregucci F, Marino L, Di Grazia A, Cucciarelli F, Borghesi S, De Santis MC, Ciabattoni A. Fozza A, et al. Among authors: borghesi s. Expert Rev Anticancer Ther. 2021 Aug;21(8):827-840. doi: 10.1080/14737140.2021.1917390. Epub 2021 Apr 25. Expert Rev Anticancer Ther. 2021. PMID: 33852379 Review.
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature.
Francolini G, Detti B, Becherini C, Caini S, Ingrosso G, Di Cataldo V, Stocchi G, Salvestrini V, Lancia A, Scartoni D, Giacomelli I, Sardaro A, Carbonara R, Borghesi S, Aristei C, Livi L. Francolini G, et al. Among authors: borghesi s. Crit Rev Oncol Hematol. 2021 Sep;165:103432. doi: 10.1016/j.critrevonc.2021.103432. Epub 2021 Aug 3. Crit Rev Oncol Hematol. 2021. PMID: 34352361 Review.
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis.
Valeriani M, Detti B, Fodor A, Caini S, Borghesi S, Trippa F, Triggiani L, Bruni A, Russo D, Saldi S, Di Staso M, Francolini G, Lancia A, Marinelli L, Di Muzio N, Aristei C, Livi L, Magrini SM, Ingrosso G. Valeriani M, et al. Among authors: borghesi s. Radiol Med. 2022 Jan;127(1):108-116. doi: 10.1007/s11547-021-01424-x. Epub 2021 Nov 8. Radiol Med. 2022. PMID: 34748151
66 results